Ticker Symbol: SRRA
Sierra Oncology Inc
$21.90 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Canada
Currency:
USD
Asset
Type: Common Stock
CIK:0001290149
Company Profile
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 2150 ? 885 West Georgia Street
Website: www.sierraoncology.com
CEO: Stephen Dilly
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
$0.02
(
0.04%)
Days Range: $54.99 - $54.99
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.04%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 24419349
Valuation
Market Cap: 134.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A